The Hartford Healthcare Fd Cl Y EBIT

As of the most recent data (December 2023), HGHYX shows a EBIT of $69M. That compares with $-110M in the prior-year period — up 164.6% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HGHYX's EBIT is now $69M (was $-110M) — a 164.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether The Hartford Healthcare Fd Cl Y is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. The Hartford Healthcare Fd Cl Y is at $69M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how HGHYX stacks up against individual peers as well.

Tracking HGHYX's ebit over time shows whether The Hartford Healthcare Fd Cl Y is scaling, shrinking, or reshaping that part of the business. The current reading is $69M That compares with $-110M in the prior-year period — up 164.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has The Hartford Healthcare Fd Cl Y's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $69M) with ownership activity and broader fundamentals.